We previously evaluated the expression of immune checkpoints (PD-1 and CTLA-4) on B cells from patients with CLL as compared to healthy controls [30], we found that in patients with CLL, the expression of PD-1 and CTLA-4 were increased in activated B cells and memory B cells. This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.